AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 22nd, 2019 • Vitality Biopharma, Inc. • Services-commercial physical & biological research
Contract Type FiledJanuary 22nd, 2019 Company IndustryThis AMENDMENT TO SECURITIES PURCHASE AGREEMENT (“Amendment”) is made and entered into as of the 18th day of January 2019 (the “Effective Date”), by and between the individuals and entities identified on the signature pages to the respective Securities Purchase Agreements dated as of August 29, 2018 and October 19, 2018 (the “SPAs”) (each, including its successors and assigns, an “Investor” and collectively, the “Investors”) and Vitality Biopharma, Inc., a Nevada corporation (the “Company”). Each of the Investors and the Company are referred to in this Agreement as a “Party”, and collectively as the “Parties”.